MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-RJ-30-0007525
Exevant Pharmaceuticals Private Limited
Exevant Pharmaceuticals Private Limited - chemicals in Sikar, Rajasthan, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹9.12 Lakh
▲ 7% YoY
Net profit · FY 2025
₹22,556
Net margin 2.5%
EBITDA · FY 2025
₹30,583
EBITDA margin 3.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Exevant Pharmaceuticals Private Limited
Data last updated:
Exevant Pharmaceuticals Private Limited is a private limited company based in Sikar, Rajasthan, India. It operates in the fine chemicals and other chemical products segment of the chemicals sector. It was incorporated on 02 March 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24299RJ2021PTC073766. Its GSTIN is 08AAGCE3539D1ZS (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mahesh Bijarniya and Girdhari Lal Jat.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Sharwan Lal Bijarniya Vill Keshav Ka Bas Distt Sikar, Rajasthan, India – 332742.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.12 Lakh, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹22,556 (net margin 2.5%) and EBITDA of ₹30,583 (EBITDA margin 3.4%). Revenue has grown at a compounded annual rate (CAGR) of 41% over three years.
Exevant Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-30-0007525).
Company details
CIN U24299RJ2021PTC073766
Registration Number 073766
Incorporation Date 02 March 2021
ROC Jaipur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-RJ-30-0007525
Recognitions & Rankings of Exevant Pharmaceuticals
Contact details
Exevant Pharmaceuticals Private Limited's registered office is in Sikar, Rajasthan. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Sharwan Lal Bijarniya Vill Keshav Ka Bas Distt Sikar, Rajasthan, India – 332742
- IndustryChemicals, Fine Chemicals And Other Chemical Products, Manufacturing, Other Chemical Product
To see the full contact details of Exevant Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Exevant Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Exevant Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Exevant Pharmaceuticals Private Limited, buy the company report.
Financials of Exevant Pharmaceuticals Private Limited
FY 2025 filings availableExevant Pharmaceuticals Private Limited reported revenue of ₹9.12 Lakh (up 7% YoY) for FY 2025.
Revenue · FY 2025
₹9.12 Lakh ▲ 7%
Net profit · FY 2025
₹22,556 margin 2.5%
EBITDA · FY 2025
₹30,583 margin 3.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 41%
EBITDA CAGR growth
1 year
▼ 24%
3 years · compounded
▲ 42%
Revenue has grown at a compounded annual rate (CAGR) of 41% over three years, including 7% growth in the latest year. EBITDA fell 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹30,583 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹22,556 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.4% | ||||
| Net Profit Margin | 2.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Exevant Pharmaceuticals Private Limited, buy the company report.
Board of directors of Exevant Pharmaceuticals Private Limited
Exevant Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahesh Bijarniya | Director | 02 Mar 2021 | 5 Years 8 Months | Current |
| Girdhari Lal Jat | Director | 02 Mar 2021 | 5 Years 8 Months | Current |
Peer comparison
Exevant Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shrine Pharmaceuticals Private Limited | ₹9.15 Lakh (FY 2025) | 8.0% | Faridabad, Haryana, India | |||
| Kingerly Pharmaceuticals Private Limited | ₹9.15 Lakh (FY 2023) | 610.0% | Nagpur, Maharashtra, India | |||
| Exevant Pharmaceuticals Private Limitedthis company | ₹9.12 Lakh (FY 2025) | ₹22,556 | 2.5% | 7.0% | Sikar, Rajasthan, India | |
| Sigmavet Pharmaceuticals Private Limited | ₹9.11 Lakh (FY 2024) | Raebareilly, Uttar Pradesh, India | ||||
| Atbu Harita Pharmaceuticals Private Limited | ₹9.11 Lakh (FY 2024) | -9.0% | Vyara, Gujarat, India |
To see the full peer comparison of Exevant Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Exevant Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Exevant Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Exevant Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 02, 2024.
Active EPFO establishments
1
GST
Exevant Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAGCE3539D1ZS | Rajasthan | Active | 10 May 2021 |
To see the full GST registrations and return filing status of Exevant Pharmaceuticals Private Limited, buy the company report.
Recent activity
Exevant Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Girdhari Lal Jat was appointed as Director on 02 Mar 2021.
AGM
Exevant Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Exevant Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Appointed
Girdhari Lal Jat was appointed as Director.
Appointed
Mahesh Bijarniya was appointed as Director.
Incorporation
02 Mar 2021
Exevant Pharmaceuticals Private Limited was registered on 02 Mar 2021 with Roc Jaipur & aged 5 years 8 months as per MCA records.
Frequently asked questions
Exevant Pharmaceuticals is an active private limited company based in Sikar, Rajasthan, India. The company works in fine chemicals and other chemical products, within the chemicals industry. It was incorporated on 02 March 2021 (5+ years old) and is registered under CIN U24299RJ2021PTC073766.
Exevant Pharmaceuticals has 2 current directors:
- Mahesh Bijarniya - Director
- Girdhari Lal Jat - Director
The latest financial statements of Exevant Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Exevant Pharmaceuticals is 08AAGCE3539D1ZS, registered in Rajasthan.
The CIN (Corporate Identification Number) of Exevant Pharmaceuticals is U24299RJ2021PTC073766. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Exevant Pharmaceuticals was incorporated on 02 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Exevant Pharmaceuticals by revenue are Shrine Pharmaceuticals Private Limited, Kingerly Pharmaceuticals Private Limited, Sigmavet Pharmaceuticals Private Limited, Atbu Harita Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Girdhari Lal Jat was appointed as Director on 02 Mar 2021. Mahesh Bijarniya was appointed as Director on 02 Mar 2021.
Yes, Exevant Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-30-0007525).
The registered office of Exevant Pharmaceuticals is at CO Sharwan Lal Bijarniya Vill Keshav Ka Bas Distt Sikar, Rajasthan, India – 332742.
Exevant Pharmaceuticals operates in the chemicals industry, in the fine chemicals and other chemical products segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages